How many studies have been conducted on Thymalfasin?

BiohacksAI has indexed 55 PubMed studies on Thymalfasin, including 6 randomized controlled trials (RCTs). 78% of studies involve human subjects.

What are the main research areas for Thymalfasin?

The primary research domains for Thymalfasin are 🛡️ Immunity, 🔬 Oncology, 🫁 Liver & Detox. This is based on analysis of 55 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thymalfasin

A thymus hormone polypeptide found in thymosin fraction 5 (a crude thymus gland extract) but now produced by synthesis. It is used alone or with interferon as an immunomodulator for the treatment of CHRONIC HEPATITIS B and HEPATITIS C. Thymalfasin is also used for the treatment of chemotherapy-induced immunosuppression, and to enhance the efficacy of influenza and hepatitis B vaccines in immunocompromised patients.

55+ PubMed studies analyzed · 6 RCTs · Evidence Score: 52.5

Research Domains

Thymalfasin has been studied across 12 research domains including 🛡️ Immunity, 🔬 Oncology, 🫁 Liver & Detox, 🔬 Inflammation, 🫘 Kidney. The primary research focus is 🛡️ Immunity with 35% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thymalfasin is generated deterministically from 55 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.